Peter Sommerness

Peter Sommerness is the President and CEO of Respicardia. He is working on technology for the treatment of central sleep apnea. Prior to Respicardia, Pete was a Partner in the healthcare practice of McKinsey & Company, a global strategy consulting firm. Pete has nearly 20 years of experience in the medical device space, including over 12 years of operating experience at Guidant Corporation and Boston Scientific – across cardiac rhythm management (CRM) and cardiac electrophysiology (EP). Pete held leadership roles in field sales, market development, upstream marketing and portfolio, and most recently led the expansion of Boston Scientific’s Cardiac Electrophysiology business as VP and General Manager.